• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AIM2 在肝脏疾病中的新作用。

The Emerging Relevance of AIM2 in Liver Disease.

机构信息

Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.

Department of Pharmacology, Paediatrics and Organic Chemistry, University Miguel Hernández (UMH), 03550 San Juan, Alicante, Spain.

出版信息

Int J Mol Sci. 2020 Sep 7;21(18):6535. doi: 10.3390/ijms21186535.

DOI:10.3390/ijms21186535
PMID:32906750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7555176/
Abstract

Absent in melanoma 2 (AIM2) is a cytosolic receptor that recognizes double-stranded DNA (dsDNA) and triggers the activation of the inflammasome cascade. Activation of the inflammasome results in the maturation of inflammatory cytokines, such as interleukin (IL)-1 β and IL-18, and a form of cell death known as pyroptosis. Owing to the conserved nature of its ligand, AIM2 is important during immune recognition of multiple pathogens. Additionally, AIM2 is also capable of recognizing host DNA during cellular damage or stress, thereby contributing to sterile inflammatory diseases. Inflammation, either in response to pathogens or due to sterile cellular damage, is at the center of the most prevalent and life-threatening liver diseases. Therefore, during the last 15 years, the study of inflammasome activation in the liver has emerged as a new research area in hepatology. Here, we discuss the known functions of AIM2 in the pathogenesis of different hepatic diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), hepatitis B, liver fibrosis, and hepatocellular carcinoma (HCC).

摘要

缺失型黑色素瘤 2(AIM2)是一种胞质受体,可识别双链 DNA(dsDNA)并触发炎症小体级联的激活。炎症小体的激活导致炎症细胞因子(如白细胞介素(IL)-1β和 IL-18)的成熟和一种称为细胞焦亡的细胞死亡形式。由于其配体的保守性质,AIM2 在多种病原体的免疫识别中非常重要。此外,AIM2 还能够在细胞损伤或应激时识别宿主 DNA,从而导致无菌性炎症性疾病。炎症,无论是对病原体的反应还是由于无菌性细胞损伤,都是最常见和危及生命的肝脏疾病的核心。因此,在过去的 15 年中,炎症小体在肝脏中的激活研究已成为肝病学的一个新研究领域。在这里,我们讨论了 AIM2 在不同肝脏疾病(包括非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)、乙型肝炎、肝纤维化和肝细胞癌(HCC))发病机制中的已知功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae2/7555176/cf446cbe35b3/ijms-21-06535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae2/7555176/447da8c635e4/ijms-21-06535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae2/7555176/cf446cbe35b3/ijms-21-06535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae2/7555176/447da8c635e4/ijms-21-06535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae2/7555176/cf446cbe35b3/ijms-21-06535-g002.jpg

相似文献

1
The Emerging Relevance of AIM2 in Liver Disease.AIM2 在肝脏疾病中的新作用。
Int J Mol Sci. 2020 Sep 7;21(18):6535. doi: 10.3390/ijms21186535.
2
AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.AIM2 缺乏可减少小鼠肝细胞癌的发展。
Int J Cancer. 2018 Dec 1;143(11):2997-3007. doi: 10.1002/ijc.31827. Epub 2018 Oct 9.
3
The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.NLRs 和 AIM2 炎性体介导热激细胞死亡在创伤性脑损伤后受损血脑屏障中的病理作用。
Brain Res. 2018 Oct 15;1697:10-20. doi: 10.1016/j.brainres.2018.06.008. Epub 2018 Jun 8.
4
The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage.P2X7R-NLRP3 和 AIM2 炎性小体平台标志着病毒或代谢性肝损伤的复杂性/严重程度。
Int J Mol Sci. 2022 Jul 4;23(13):7447. doi: 10.3390/ijms23137447.
5
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
6
Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.心磷脂抑制剂通过抑制 NLRP3 炎性小体的激活来改善非酒精性脂肪性肝炎。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8158-8167. doi: 10.26355/eurrev_201909_19036.
7
Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression.人肝细胞表达黑色素瘤缺失因子2并通过白细胞介素-18表达对乙型肝炎病毒作出反应。
Virus Genes. 2016 Aug;52(4):445-52. doi: 10.1007/s11262-016-1327-9. Epub 2016 Apr 19.
8
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.NAG-1/GDF15 的过表达通过抑制氧化应激介导的双链 DNA 释放和 AIM2 炎性小体激活来防止肝脂肪变性。
Redox Biol. 2022 Jun;52:102322. doi: 10.1016/j.redox.2022.102322. Epub 2022 Apr 27.
9
Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.AIM2 炎性小体在炎症性疾病、癌症和感染中的作用。
Eur J Immunol. 2019 Nov;49(11):1998-2011. doi: 10.1002/eji.201848070. Epub 2019 Aug 14.
10
Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease.线粒体 DNA 可激活非酒精性脂肪性肝病中的 AIM2 炎性体并诱导肝细胞发生细胞焦亡。
Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G1034-G1044. doi: 10.1152/ajpgi.00431.2020. Epub 2021 Mar 17.

引用本文的文献

1
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.细胞焦亡在肝脏疾病中的双重作用:机制、影响及治疗前景
Front Cell Dev Biol. 2025 Jan 23;13:1522206. doi: 10.3389/fcell.2025.1522206. eCollection 2025.
2
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018.全身免疫炎症指标对肝脂肪变性和肝纤维化的不同影响:来自1999 - 2018年美国国家健康与营养检查调查(NHANES)的证据
BMC Gastroenterol. 2024 Dec 18;24(1):463. doi: 10.1186/s12876-024-03557-5.
3
Neutrophil extracellular traps facilitate liver inflammation/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis.

本文引用的文献

1
Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease.为什么我们需要遏制全球范围内非酒精性脂肪性肝病这一新兴流行病。
Nat Metab. 2019 Nov;1(11):1027-1029. doi: 10.1038/s42255-019-0140-x.
2
Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models.N-亚硝基二甲胺的代谢、大分子的甲基化与啮齿类动物模型肝纤维化的发展。
J Mol Med (Berl). 2020 Sep;98(9):1203-1213. doi: 10.1007/s00109-020-01950-7. Epub 2020 Jul 14.
3
Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases.
中性粒细胞胞外诱捕网通过进入巨噬细胞并触发 AIMP 炎性小体依赖性细胞焦亡来促进肝脏炎症/纤维化进展。
Cell Commun Signal. 2024 Nov 20;22(1):556. doi: 10.1186/s12964-024-01944-9.
4
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer.炎症小体相关固有免疫受体在癌症中的作用
Immune Netw. 2024 Oct 21;24(5):e38. doi: 10.4110/in.2024.24.e38. eCollection 2024 Oct.
5
The Role of the AIM2 Gene in Obesity-Related Glucose and Lipid Metabolic Disorders: A Recent Update.AIM2基因在肥胖相关糖脂代谢紊乱中的作用:最新进展
Diabetes Metab Syndr Obes. 2024 Oct 21;17:3903-3916. doi: 10.2147/DMSO.S488978. eCollection 2024.
6
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?细胞质 DNA 与 RA 中的 AIM2 炎性体:它们从何而来,又将去往何处?
Front Immunol. 2024 Oct 10;15:1343325. doi: 10.3389/fimmu.2024.1343325. eCollection 2024.
7
Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization.肝细胞癌与 AIM2:通过调控自噬和巨噬细胞极化的治疗潜力。
Immun Inflamm Dis. 2024 Sep;12(9):e70002. doi: 10.1002/iid3.70002.
8
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk.与非酒精性脂肪性肝病风险相关的系统性免疫炎症生物标志物(SII、NLR、PLR 和 LMR)。
Front Immunol. 2024 Feb 28;15:1337241. doi: 10.3389/fimmu.2024.1337241. eCollection 2024.
9
AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3.AIM2 通过调节肿瘤相关巨噬细胞中的 PD-L1 表达,经由 JAK/STAT3 促进长腺癌的免疫逃逸。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2269790. doi: 10.1080/21645515.2023.2269790. Epub 2023 Oct 25.
10
Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.泛癌症分析 AIM2 炎性体,对人类癌症的免疫治疗具有潜在意义:批量组学研究和单细胞测序验证。
Front Immunol. 2022 Sep 29;13:998266. doi: 10.3389/fimmu.2022.998266. eCollection 2022.
含NOD样受体蛋白3炎症小体参与肝脏疾病的发病机制
Front Cell Dev Biol. 2020 Mar 10;8:139. doi: 10.3389/fcell.2020.00139. eCollection 2020.
4
Toll-like Receptors and the Control of Immunity. toll 样受体与免疫的调控。
Cell. 2020 Mar 19;180(6):1044-1066. doi: 10.1016/j.cell.2020.02.041. Epub 2020 Mar 11.
5
Aim2-mediated/IFN-β-independent regulation of gastric metaplastic lesions via CD8+ T cells.Aim2 介导/IFN-β 非依赖性调控 CD8+T 细胞致胃化生病变。
JCI Insight. 2020 Mar 12;5(5):94035. doi: 10.1172/jci.insight.94035.
6
Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent IL-1β Production.炎症小体依赖性 IL-1β 产生引发感染诱导的肝星状细胞介导的肝纤维化。
Front Immunol. 2020 Jan 21;10:3036. doi: 10.3389/fimmu.2019.03036. eCollection 2019.
7
AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.AIM2 通过调节线粒体动力学促进非小细胞肺癌的发展。
Oncogene. 2020 Mar;39(13):2707-2723. doi: 10.1038/s41388-020-1176-9. Epub 2020 Jan 31.
8
Novel Evidence that Purinergic Signaling - Nlrp3 Inflammasome Axis Regulates Circadian Rhythm of Hematopoietic Stem/Progenitor Cells Circulation in Peripheral Blood.嘌呤能信号-NLRP3 炎性小体轴调控造血干细胞/祖细胞在外周血循环中的生物钟。
Stem Cell Rev Rep. 2020 Apr;16(2):335-343. doi: 10.1007/s12015-020-09953-0.
9
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment.肝细胞癌的动物模型:免疫系统和肿瘤微环境的作用
Cancers (Basel). 2019 Oct 2;11(10):1487. doi: 10.3390/cancers11101487.
10
Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance.AIM2 缺乏会导致白色脂肪组织炎症和脂肪生成,从而导致肥胖和胰岛素抵抗。
Diabetologia. 2019 Dec;62(12):2325-2339. doi: 10.1007/s00125-019-04983-x. Epub 2019 Sep 11.